Raymond James & Associates’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.24M | Sell |
|
|||||
|
2024
Q2 | $1.12M | Sell |
|
|||||
|
2024
Q1 | $1.77M | Buy |
|
|||||
|
2023
Q4 | $575K | Buy |
|
|||||
|
2023
Q3 | $379K | Buy |
|
|||||
|
2023
Q2 | $244K | Sell |
|
|||||
|
2023
Q1 | $259K | Buy |
|
|||||
|
2022
Q4 | $108K | Sell |
|
|||||
|
2022
Q3 | $238K | Buy |
|
|||||
|
2022
Q2 | $208K | Sell |
|
|||||
|
2022
Q1 | $268K | Buy |
|
|||||
|
2021
Q4 | $375K | Sell |
|
|||||
|
2021
Q3 | $938K | Buy |
|
|||||
|
2021
Q2 | $907K | Buy |
|
|||||
|
2021
Q1 | $979K | Buy |
|
|||||
|
2020
Q4 | $1.2M | Sell |
|
|||||
|
2020
Q3 | $711K | Buy |
|
|||||
|
2020
Q2 | $754K | Buy |
|
|||||
|
2020
Q1 | $315K | Buy |
|